Gastroenterology News

A pharmacy-based, multicomponent intervention program reduced proton pump inhibitor use overall and also when appropriate for gastroprotection, with little evidence of either clinical harms or benefits, according to a study in BMJ.

In a Healio video exclusive, Wendi LeBrett, MD, winner of the 2023 Healio Social Media Influencer Award, discusses how she uses social media, namely TikTok, to address misleading or inaccurate information about gastrointestinal diseases.

The 10-year interval between screening colonoscopies “could potentially be extended” to 15 years among patients without a family history of colorectal cancer and negative findings for CRC at the first colonoscopy, researchers reported.

DENVER — Prior studies have shown that many diseases are tied to the gut microbiome, including metabolic disorders such as obesity, according to Sahil Khanna, MBBS, MS, FACG, AGAF.

In this podcast episode, Tom Shehab, MD, managing partner at Arboretum Ventures, discusses supporting “doctorpreneurs," alternative career paths for physicians and more.

BOSTON — Chronic diarrhea is an “incredibly common” condition, with about one out of 20 patients presenting with symptoms, according to Brian E. Lacy, MD, PhD, FACG, a professor of medicine at the Mayo Clinic.

In this Healio video exclusive, Jeffrey Roberts, MS, BSc, shares details about World IBS Day, April 19, which aims to raise awareness and support for patients with irritable bowel syndrome with the theme, “Light Up the Sky for IBS.”

In this video, Laurie Keefer, PhD, Healio’s 2023 Allied Health Provider of the Year, underscores the importance of providing interventions to patients at the time of a GI diagnosis — not just when symptoms of depression or anxiety develop.

Only half of rheumatologists are “extremely comfortable” prescribing the Humira biosimilar Amjevita, while just 16% can say the same for all other adalimumab biosimilars combined, according to a market analysis from Spherix Global Insights.

Most patients with all-cause and norovirus-associated acute gastroenteritis have only one health care encounter, primarily in the outpatient setting, researchers found in a study.